KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oscar Health (OSCR) EBIT (2020 - 2025)

Oscar Health's EBIT history spans 6 years, with the latest figure at $265.6 million for Q4 2025.

  • For Q4 2025, EBIT rose 1478.27% year-over-year to $265.6 million; the TTM value through Dec 2025 reached $669.9 million, up 440.05%, while the annual FY2025 figure was $202.9 million, 9.27% up from the prior year.
  • EBIT reached $265.6 million in Q4 2025 per OSCR's latest filing, up from $53.2 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $297.1 million in Q1 2025 to a low of -$598.9 million in Q4 2022.
  • Average EBIT over 5 years is -$6.0 million, with a median of $1.9 million recorded in 2021.
  • Peak YoY movement for EBIT: tumbled 13062.62% in 2021, then skyrocketed 1478.27% in 2025.
  • A 5-year view of EBIT shows it stood at -$196.3 million in 2021, then tumbled by 205.18% to -$598.9 million in 2022, then surged by 141.0% to $245.6 million in 2023, then crashed by 107.85% to -$19.3 million in 2024, then surged by 1478.27% to $265.6 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's EBIT are $265.6 million (Q4 2025), $53.2 million (Q3 2025), and $54.0 million (Q2 2025).